(Q43965394)

English

Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.

scientific article published on 5 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

Michael Boe Møller

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Henrik J. Ditzel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lars M Rasmussen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Ida B Kristensen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jacob Haaber Christensen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Maria B Lyng

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Niels Abildgaard

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

5 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

55

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

911-919

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wnt signaling in osteoblasts and bone diseases

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Wnt signaling in B-cell neoplasia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Wnt signaling controls the fate of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Myeloma cells suppress osteoblasts through sclerostin secretion

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Effects of Secreted Frizzled-Related Protein 3 on Osteoblasts In Vitro

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.820288

21 January 2018

Identifiers

10.3109/10428194.2013.820288

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23915193%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43965394&oldid=2105092402"